What is GenesisCare?
GenesisCare is a prominent Australian healthcare company specializing in advanced treatments for cancer and cardiovascular diseases. Its core services encompass radiation therapy and medical oncology, positioning it as a key player in delivering comprehensive patient care. The company's focus on specialized medical services highlights its strategic importance within the healthcare sector.
How much funding has GenesisCare raised?
GenesisCare has raised a total of $325M across 1 funding round:
Private Equity
$325M
Private Equity (2014): $325M with participation from CPP Investments
Key Investors in GenesisCare
CPP Investments
CPP Investments is a significant financial backer, likely focused on long-term, strategic investments in established companies within the healthcare sector.
What's next for GenesisCare?
The recent major strategic investment into GenesisCare signals a new phase of expansion and development. This substantial capital infusion is expected to fuel further innovation in its treatment modalities, potentially broaden its geographical reach, and enhance its operational capabilities. The enterprise-level funding suggests a strategic focus on scaling its existing infrastructure and exploring new avenues for growth within the competitive healthcare landscape.
See full GenesisCare company page
